MUSCLE EDEMA IN MUSCULOSKELETAL TUMORS - MR IMAGING CHARACTERISTICS AND CLINICAL-SIGNIFICANCE

被引:50
作者
HANNA, SL [1 ]
FLETCHER, BD [1 ]
PARHAM, DM [1 ]
BUGG, MF [1 ]
机构
[1] ST JUDE CHILDRENS RES HOSP, DEPT DIAGNOST IMAGING, POB 318, 332 N LAUDERDALE, MEMPHIS, TN 38101 USA
关键词
BONE NEOPLASMS; BONE NEOPLASM; MR STUDIES; CONTRAST ENHANCEMENT; GADOLINIUM; MUSCLES; NEOPLASMS; SOFT TISSUES;
D O I
10.1002/jmri.1880010408
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
To determine the frequency and clinical significance of tumor-associated muscle edema, magnetic resonance (MR) imaging findings in 46 consecutive patients with benign or malignant musculoskeletal lesions were reviewed. Increased muscle signal intensity on T2-weighted. STIR (short-inversion-time inversion-recovery), and gadopentetate dimeglumine-enhanced T1-weighted images was present in 41 cases, with the clearest delineation of tumor margins seen on T2-weighted images. Typical peri/paratumoral edema (PTE) was present in equal proportions of malignant (25 of 37) and benign lesions (six of nine). Massive edema involving the entirety of at least one contiguous muscle to the authors' knowledge, a previously undescribed finding-was identified on MR images of eight malignant and two benign lesions (22% of both groups). All cases of massive edema had a substantial soft-tissue component and involved muscles disrupted by tumor at the point of attachment to bone. Malignant tumors associated with massive edema were larger than those with typical or no PTE, showed a poorer response to initial chemotherapy. and had a higher frequency of metastases at diagnosis. Thus, the presence of massive muscle edema appears to be an ominous clinical finding in patients with malignant musculoskeletal lesions.
引用
收藏
页码:441 / 449
页数:9
相关论文
共 17 条
  • [1] Mitchell DG, Burk DL, Vinitski S, Rifkin MD, The biophysical basis of tissue contrast in extracranial MR imaging, AJR, 149, pp. 831-837, (1987)
  • [2] Beltran J, Simon DC, Katz W, Weis LD, Increased MR signal intensity in skeletal muscle adjacent to malignant tumors: pathologic correlation and clinical relevance, Radiology, 162, pp. 251-255, (1987)
  • [3] Erlemann R, Reiser MF, Peters PE, Et al., Musculoskeletal neoplasms: static and dynamic Gd‐DTPA‐enhanced MR imaging, Radiology, 19, pp. 171-773, (1989)
  • [4] Pan G, Raymond AK, Carrasco CH, Et al., Osteosarcoma: MR imaging after preoperative chemotherapy, Radiology, 174, pp. 517-526, (1990)
  • [5] Harkens KL, Yuh WTC, Kathol MH, Et al., Differentiating musculoskeletal neoplasms from nonneoplastic process: value of MR and Gd‐DTPA (abstr). Society of Magnetic Resonance in Medicine 1989, (1989)
  • [6] Hanna SL, Fletcher BD, Fairclough D, Le A, Use of dynamic Gd‐DTPA‐enhanced MRI in muscutoskeletal malignancies (abstr), Magn Reson Imaging, 8, (1990)
  • [7] Miller AB, Hoogstraten B, Staquet M, Winkler A, Reporting results of cancer treatment, Cancer, 47, pp. 207-214, (1981)
  • [8] Brant-Zawadzki M, Badami JP, Mills CM, Norman D, Newton TH, Primary intracranial tumor imaging: a comparison of magnetic resonance and CT, Radiology, 150, pp. 435-440, (1984)
  • [9] Liddell RM, Shuman WP, Weinberger E, Conrad EU, Lazerte GG, Prospective anatomic and histologic correlation of increased MR signal intensity in skeletal muscle adjacent to tumor (abstr), Radiology, 173, P, (1989)
  • [10] Enneking WF, A system of staging musculoskeletal neoplasms, Clin Orthop, 204, pp. 9-24, (1986)